Latest filing published 01 Apr 2022 for Aarti Drugs Limited, €131k.
Harit Pragji Shah, listed as chief executive, appears in our data through filings on Aarti Drugs Limited shares, published by SEBI (PIT + SAST). In total, 3 filings cover trades dated from 18 May 2021 to 31 March 2022.
Every open-market trade on record is a purchase: 1 purchase worth €131k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.
The newest entry dates from 1 April 2022: an open-market purchase of €131k, in Aarti Drugs Limited. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations